» Articles » PMID: 36798271

Cell State Transition Analysis Identifies Interventions That Improve Control of Infection by Susceptible Macrophages

Overview
Journal bioRxiv
Date 2023 Feb 17
PMID 36798271
Authors
Affiliations
Soon will be listed here.
Abstract

Understanding cell state transitions and purposefully controlling them to improve therapies is a longstanding challenge in biological research and medicine. Here, we identify a transcriptional signature that distinguishes activated macrophages from TB-susceptible and TB-resistant mice. We then apply the cSTAR (cell State Transition Assessment and Regulation) approach to data from screening-by-RNA sequencing to identify chemical perturbations that shift the. transcriptional state of the TB-susceptible macrophages towards that of TB-resistant cells. Finally, we demonstrate that the compounds identified with this approach enhance resistance of the TB-susceptible mouse macrophages to virulent .

References
1.
Su Y, Ko M, Cheng H, Zhu R, Xue M, Wang J . Multi-omic single-cell snapshots reveal multiple independent trajectories to drug tolerance in a melanoma cell line. Nat Commun. 2020; 11(1):2345. PMC: 7214418. DOI: 10.1038/s41467-020-15956-9. View

2.
Bhattacharya B, Xiao S, Chatterjee S, Urbanowski M, Ordonez A, Ihms E . The integrated stress response mediates necrosis in murine Mycobacterium tuberculosis granulomas. J Clin Invest. 2020; 131(3). PMC: 7843230. DOI: 10.1172/JCI130319. View

3.
Yabaji S, Chatterjee S, Waligursky E, Gimelbrant A, Kramnik I . Medium throughput protocol for genome-based quantification of intracellular mycobacterial loads and macrophage survival during infection. STAR Protoc. 2022; 3(2):101241. PMC: 8931439. DOI: 10.1016/j.xpro.2022.101241. View

4.
Fey D, Halasz M, Dreidax D, Kennedy S, Hastings J, Rauch N . Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients. Sci Signal. 2015; 8(408):ra130. DOI: 10.1126/scisignal.aab0990. View

5.
Arish M, Naz F . Macrophage plasticity as a therapeutic target in tuberculosis. Eur J Immunol. 2022; 52(5):696-704. DOI: 10.1002/eji.202149624. View